ライフサイエンスコーパス: MIC

1 MIC allele profiles were determined in a discovery cohor

2 MIC and disk diameter results were interpreted using Uni

3 MIC determinations were performed retrospectively for th

4 MIC distributions and susceptibilities were also compare

5 MIC of colistin (4 mug/ml) for DH5alpha containing mcr-3

6 MIC values for agar dilution, Etest, and MTS were not si

7 MIC, pDST and whole genome sequencing of the pncA, rpsA

8 MIC-treated patients showed the Immune Tolerance Network

9 MICs for macrolide-susceptible M. pneumoniae (MSMp) were

10 MICs inhibiting 50 and 90% of organisms (MIC(50) and MIC

11 MICs were determined in triplicate via reference broth m

12 MICs were evaluated visually and interpreted using Clini

13 MICs were interpreted according to the investigational C

14 I trial, patients received either 1.5 x 106 MICs per kg BW on day -2 (n = 3, group A), or 1.5 x 108

15 BW on day -2 (n = 3, group A), or 1.5 x 108 MICs per kg BW on day -2 (n = 3, group B) or day -7 (n =

16 i MG1655:: tetA grown in the presence of 1/2 MIC (14 mg/L) of OTC, and for comparison WT MG1655 strai

17 comparison WT MG1655 strain grown with 1//2 MIC of OTC (0.25 mg/L OTC).

18 ocycline susceptibility results (+/-1 log(2) MIC agreement) of AXDX MICs with reference broth microdi

19 ic-pharmacodynamic studies identify fAUC0-24/MIC ratio as the parameter that correlates with in vivo

20 otoxic to host macrophages at both 1X and 5X MIC.

21 odified carbapenem inactivation method and a MIC screen for ertapenem, imipenem, and meropenem.

22 resistance breakpoint our results suggest a MIC of 32 mg/L to be considered in order to detect isola

23 um and Colletotrichum gloeosporioides with a MIC dosage of 0.1% (v/v) for both phytopathogens.

24 C (MIC(50) = 0.25 mug/ml) and mithramycin A (MIC(50) = 0.015 mug/ml), and the naturally derived tetra

25 that the laboratory can generate an accurate MIC that is reproducible within one interpretive categor

26 training sets, we show that highly accurate MIC prediction models can be generated with less than 50

27 cephalosporins (amoxicillin/clavulanic acid MIC >= 256 mug/mL; ceftriaxone MIC >= 8 mug/L).

28 w approach provides quantitative, actionable MIC results within just 5 h because it measures electric

29 ones, evaluated their antifungal activities (MIC(80) and time-kill profile) against C. neoformans, an

30 ifficile agents with ultrapotent activities [MICs as low as 0.003 mug/mL (0.007 muM)] that surpassed

31 3.3 showed the greatest antibiotic activity (MIC = 15.6 mug/mL) against Gram-positive bacteria and gr

32 ted activity against Pseudomonas aeruginosa (MIC 16 ug/mL) and Staphylococcus aureus (MIC 64 ug/mL).

33 2-fold increased penicillin G and ampicillin MIC among the isolates tested.

34 but gradient diffusion strips identified an MIC of >=4 for colistin for only 62.5% of these isolates

35 sistant Staphylococcus aureus (MRSA) with an MIC of 1.4 mug/mL.

36 ance range (i.e., 42.6% for isolates with an MIC within 1 dilution of the breakpoint).

37 This study was performed to analyze MIC gene profiles in hospitalized Thai children with acu

38 er) than the community isolates (MIC(50) and MIC(90) of 0.5 mg/liter), a finding that was consistent

39 ed higher CPT MIC distributions (MIC(50) and MIC(90) of 2 mg/liter) than the community isolates (MIC(

40 ibiting 50 and 90% of organisms (MIC(50) and MIC(90), respectively), essential agreement (EA), catego

41 Genotypic DST and MIC for PZA were not associated with treatment outcome.

42 e aimed to assess the impact of PZA gDST and MIC on time to sputum culture conversion (SCC) and treat

43 ) of 0.6-2.7 muM, IC(90) of 0.7-3.9 muM, and MIC of 1.6-10 muM.

44 ), Etest (bioMerieux, Inc., Durham, NC), and MIC test strip (MTS) (Liofilchem, Inc., Waltham, MA) met

45 Susceptibility rates, MIC(50) values, and MIC(90) values were as follows: ceftazidime-avibactam, 9

46 ues of B1, showing comparable haemolysis and MICs against MRSP and P. aeruginosa.

47 llin to predict target molecule occupancy at MIC from antimicrobial action with 90% accuracy.

48 Alternative day 2 AUC/MIC thresholds associated with lower TF risks were not i

49 Achievement of the prespecified day 2 AUC/MIC thresholds was not associated with less TF.

50 These consensus guidelines recommend an AUC/MIC ratio of 400-600 mg*hour/L (assuming a broth microdi

51 AUC/MIC by broth microdilution >=650 and AUC/MIC by Etest >=320.

52 rve to minimum inhibitory concentration (AUC/MIC) thresholds previously found to be associated with l

53 urs to minimum inhibitory concentration (AUC/MIC).

54 separately as co-primary endpoints, were AUC/MIC by broth microdilution >=650 and AUC/MIC by Etest >=

55 f 0.063, 0.125, and 0.25 mg/L achieved AUC24/MIC >= 125.

56 of 0.063, 0.125 and 0.25 mg/L achieved AUC24/MIC >=125.

57 An AUC24/MIC of >=125 was defined as target ratio.

58 over minimal inhibitory concentration (AUC24/MIC) ratios, and emergence of resistance were studied.

59 over minimal inhibitory concentration (AUC24/MIC) ratios, and emergence of resistance were studied.

60 derived tetracycline derivative, aureomycin (MIC(50) = 0.06 mug/ml), exhibited potent activity agains

61 against multiresistant Staphylococcus aureus MIC = 5 mg/mL) and no cytotoxicity against carcinogenic

62 sa (MIC 16 ug/mL) and Staphylococcus aureus (MIC 64 ug/mL).

63 ) and Harungana madagascariensis (S. aureus: MIC: 32 mug/mL; E. faecium: MIC: 32 mug/mL) stem bark.

64 anthoxylum chalybeum (Staphylococcus aureus: MIC: 16 mug/mL; Enterococcus faecium: MIC: 32 mug/mL) an

65 solate collection with ceftazidime-avibactam MIC values near the breakpoints.

66 results (+/-1 log(2) MIC agreement) of AXDX MICs with reference broth microdilution was 98.0% (96/98

67 and theoretical investigations show that Azo-MICs are potent sigma-donor ligands.

68 Nevertheless, using an agar-based MIC assay, we found that propionylation of Lys280 on Ade

69 h of both CRAB and susceptible A. baumannii (MIC 64-256 ug/mL), and also exhibited activity against P

70 sensitivity and specificity of a bedaquiline MIC susceptibility breakpoint of 0.12 mug/ml for the BMD

71 d reproducibility of provisional bedaquiline MIC breakpoints and World Health Organization interim cr

72 (Bregs) increased from a median of 6% before MIC infusion to 20% on day 180, which was 19- and 68-fol

73 l resistance to penicillin (benzylpenicillin MIC >= 256 mug/ml), beta-lactam/beta-lactamase inhibitor

74 were 1 doubling dilution apart from the BMD MICs.

75 illin/tazobactam non-susceptible breakpoint (MIC > 16 mg/L) best predicted 30-day mortality after acc

76 in the presence of serum and whole blood by MIC and minimal bactericidal concentration (MBC) determi

77 concept, botanical samples were digested by MIC-DV for further determination of Al, Cr, Cu, Fe, Mn,

78 Limits of quantification obtained by MIC were 0.034 (As), 0.015 (Cd), 0.021 (Hg) and 0.105 (P

79 The anticancer drugs, mitomycin C (MIC(50) = 0.25 mug/ml) and mithramycin A (MIC(50) = 0.01

80 avulanic acid MIC >= 256 mug/mL; ceftriaxone MIC >= 8 mug/L).

81 ess on the fate of myeloma initiating cells (MICs), we develop a systems biological model to reveal t

82 an alkylating agent (modified immune cells [MICs]), induced long-term specific immunosuppression aga

83 port use of standard AD for determining CFDC MICs.

84 tance mechanisms, and 128 isolates with CFDC MICs of >=8 mug/ml obtained from International Health Ma

85 t decades, and molecular information coding (MIC) on those designed nanostructures has gained increas

86 MicroScan colistin well displayed a colistin MIC of >=4 by BMD, all were determined to be negative fo

87 CR) genes based on any reduction of colistin MIC in the presence of EDTA.

88 microdilution (BMD) for identifying colistin MICs.

89 such, the results for isolates with colistin MICs of 2 ug/ml by CBDE should be confirmed by the refer

90 PmB (MICs 384-1024 ug ml(-1) ) and colistin (MIC 256 ug ml(-1) ) as well as enhanced LL-37 resistance

91 Microwave-induced combustion (MIC) system for further Cl, Br, and I determination in g

92 m pressure and microwave-induced combustion (MIC) were evaluated.

93 us aureus [minimum inhibitory concentration (MIC) = 4 ug/mL], while the blue benzoquinone is active a

94 meropenem minimum inhibitory concentration (MIC) and beta-lactam resistance genes with mortality in

95 erform the minimum inhibitory concentration (MIC) assays, which indicated that frtP upregulation led

96 h standard minimum inhibitory concentration (MIC) assays.

97 (gDST) and minimum inhibitory concentration (MIC) could be beneficial.

98 above the minimum inhibitory concentration (MIC) for many fungi.

99 ion of the minimum inhibitory concentration (MIC) in 60 min (p < 0.03).

100 al test of minimum inhibitory concentration (MIC) is not informative enough to guide effective antibi

101 anner with minimum inhibitory concentration (MIC) of 125 mM.

102 d that the minimum inhibitory concentration (MIC) of RSM-932A and MN58b for S. pneumoniae was 0.4 muM

103 reased the minimum inhibitory concentration (MIC) of S. aureus towards vancomycin by 75%, and resulte

104 The minimum inhibitory concentration (MIC) of the peptide ranged from 80 mug/ml for X. citri t

105 Minimum inhibitory concentration (MIC) testing, unlike routine drug susceptibility testing

106 urve (AUC)/minimum inhibitory concentration (MIC) to ensure clinical efficacy and minimize toxicity i

107 A), with a minimum inhibitory concentration (MIC) value as low as 0.5 mug/mL.

108 idomycins (minimum inhibitory concentration (MIC) values around 2.5 muM), with several analogs thus a

109 The minimum inhibitory concentration (MIC) values generated from our technique are validated b

110 H37Rv with minimum inhibitory concentration (MIC) values of 9.65 and 22.28 muM, respectively.

111 sub-mug/mL minimum inhibitory concentration (MIC) values] against Gram-positive bacteria.

112 bition and minimum inhibitory concentration (MIC) with that of nisin A and its antimicrobial effect i

113 t strain's minimum inhibitory concentration (MIC).

114 ablish its minimum inhibitory concentration (MIC).

115 n than the minimum inhibitory concentration (MIC).

116 ermine the minimum inhibitory concentration (MIC).

117 cocci (ie, minimum inhibitory concentration [MIC] <=4 mg/L) is appropriate.

118 minimum inhibitory/biocidal concentrations (MIC/MBC), and disc diffusion assays against Meticillin-r

119 microbial minimal inhibitory concentrations (MIC) by agar dilution.

120 g2 showed minimum inhibitory concentrations (MIC) down to 15.6 umol/L and were thus 10-1,000-fold mor

121 size, and minimal inhibitory concentrations (MIC) were determined.

122 , and the minimum inhibitory concentrations (MIC) were then determined via simple colorimetric reacti

123 cidal and minimal inhibitory concentrations (MIC), are independent of bacterial resistance pattern, p

124 ed potent minimum inhibitory concentrations (MICs) against canine S. pseudintermedius and P. aerugino

125 tric mean minimum inhibitory concentrations (MICs) as the outcome variables (from 2010 to 2016).

126 microbial minimum inhibitory concentrations (MICs) by agar dilution.

127 termining minimum inhibitory concentrations (MICs) especially by broth dilution.

128 Minimum inhibitory concentrations (MICs) for ampicillin and amoxicillin were 8-fold higher,

129 Minimum inhibitory concentrations (MICs) for ampicillin and amoxicillin were 8-fold higher,

130 mpared to minimal-inhibitory concentrations (MICs) in laboratory media, AZM had a 16-fold lower MIC i

131 measured minimum inhibitory concentrations (MICs) to ciprofloxacin, cefixime, ceftriaxone, and cefpo

132 bacterial minimum inhibitory concentrations (MICs) were used to determine therapeutic versus subthera

133 ded the lowest error rates, but confirmatory MIC testing is indicated for isolates with inhibition zo

134 z holder (a modified version of conventional MIC) placed inside disposable polypropylene (PP) vessels

135 dentification on Intel Many Integrated Core (MIC) architecture.

136 Therefore, we correlated MICs of first- and second-line tuberculosis drugs with t

137 d Cox proportional hazard models correlating MICs, DST results, and clinical variables to tSCC and tr

138 e countries (HICs), middle-income countries (MICs), and low-income countries (LICs) with standardised

139 tal-associated isolates exhibited higher CPT MIC distributions (MIC(50) and MIC(90) of 2 mg/liter) th

140 We found that the meiotic crescent MIC has a specific chromosome interaction pattern, with

141 Herein, we demonstrated MIC in a reconfigurable DNA origami domino array (DODA),

142 In addition to determining MICs of antibiotics (ceftazidime, gentamicin, meropenem,

143 p, here we developed a droplet-based digital MIC screen that constitutes a practical analytical platf

144 M23-defined tier 2 study, the agar dilution MIC QC range for zoliflodacin against the Neisseria gono

145 ates exhibited higher CPT MIC distributions (MIC(50) and MIC(90) of 2 mg/liter) than the community is

146 insic resistance to fluconazole and elevated MIC to voriconazole (81%), amphotericin B (61%), flucyto

147 These errors resulted when P/T Etest MICs were 1 doubling dilution apart from the BMD MICs.

148 bisected the wild-type Enterococcus faecium MIC distribution.

149 nsis (S. aureus: MIC: 32 mug/mL; E. faecium: MIC: 32 mug/mL) stem bark.

150 ureus: MIC: 16 mug/mL; Enterococcus faecium: MIC: 32 mug/mL) and Harungana madagascariensis (S. aureu

151 r enterococcal bacteremia, a daptomycin fAUC/MIC >27.43 was associated with 30-day survival among low

152 concentration-time curve to MIC ratio (fAUC/MIC) threshold predictive of survival at 30 days was ide

153 all the telomeres or centromeres on the five MIC chromosomes clustering together, respectively, which

154 ty of fosfomycin is the specified method for MIC determination, namely, agar dilution, which is not w

155 ed potency against clinical VRE strains from MIC = 2 mug/mL (acetazolamide) to MIC = 0.007 mug/mL (22

156 ts were from HICs, 102 680 (65.9%) were from MICs, and 35 793 (23.0%) from LICs.

157 Overall, 89 (25.9%) isolates had MICs >= 32 mg/L to azithromycin, decreasing to 42 (12.2%

158 contemporary cohort of adults from 21 HICs, MICs, and LICs across five continents by use of standard

159 iddle-income, or low-income countries (HICs, MICs, or LICs).

160 ithout antibiotic was low, confirmed by high MIC/MBC, and a no inhibition on agar lawns.

161 ositive isolates were associated with higher MIC distributions.

162 voriconazole exhibited significantly higher MICs against isolates of the South African lineage than

163 een baseline and follow-up by the identified MIC (0.301) reported lower treatment satisfaction at fol

164 ent model indicated that a small increase in MIC might decrease the efficacy of vancomycin in clearin

165 KPC-2 this results in a 16-fold increase in MIC to Meropenem.

166 No significant differences were observed in MIC distributions across the 3 strata evaluated.

167 In MICs and LICs, household air pollution, poor diet, low e

168 to those from cancer was 0.4 in HICs, 1.3 in MICs, and 3.0 in LICs, and four upper-MICs (Argentina, C

169 ed for only 23% of deaths in HICs (vs 41% in MICs and 43% in LICs), despite more cardiovascular disea

170 ICs (7.1 cases per 1000 person-years) and in MICs (6.8 cases per 1000 person-years) than in HICs (4.3

171 rythromycin and tetracycline, differences in MICs between WT and DeltaTolC mutant strains were not re

172 provide a zinc-limited medium, resulting in MICs that reflect in vivo meropenem activity.

173 per 1000 person-years) were double those in MICs (6.9 deaths per 1000 person-years) and four times h

174 Further studies, including MIC testing and clinical outcome data to define clinical

175 ated with Neisseria species having increased MICs to cefixime, ceftriaxone, and cefpodoxime (mean MIC

176 Increasing MICs of fluoroquinolones were correlated with unsuccessf

177 Increasing MICs of fluoroquinolones, diabetes, and age >40 years we

178 mpounds that exhibited bacterial inhibition (MIC) and killing (MBC) activities up to 65 folds higher

179 of 2 mg/liter) than the community isolates (MIC(50) and MIC(90) of 0.5 mg/liter), a finding that was

180 To date, this is one of the largest MIC modeling studies to be published.

181 g with initial zinc availability (i.e., less MIC reduction with higher initial zinc concentrations),

182 eller Hinton broth (MHB) and a 64-fold lower MIC in this tissue culture medium with 20% human serum.

183 in laboratory media, AZM had a 16-fold lower MIC in tissue culture medium with 5% Mueller Hinton brot

184 In association, an interesting lower MIC and MBC values (2048 mg/L and 4096 mg/L respectively

185 5.5% [44.8-46.4] 2015 GNI for LICs and lower-MICs combined) and interventions delivered in health cen

186 9.8% [49.5-50.2] 2015 GNI for LICs and lower-MICs combined) would each comprise the plurality of cost

187 Cs) and lower-middle-income countries (lower-MICs).

188 37.9] in LICs and 43.0% [42.6-43.4] in lower-MICs).

189 2015 GNI in LICs and 2.0% [1.4-2.8] in lower-MICs).

190 .7-11.3) in LICs and 4.2% (2.9-5.9) in lower-MICs.

191 ICs and US$130 (100-180) per capita in lower-MICs.

192 ns of chloramphenicol or gentamicin, lowered MIC towards OTC.

193 tibility rate overall (92.7%) and the lowest MIC(90) value (4 mg/liter) of any of the 12 agents teste

194 disposable vessels and instrumentation, make MIC-DV suitable to be used for research and routine anal

195 cefixime, ceftriaxone, and cefpodoxime (mean MIC ratios of 6.27, 4.11, and 7.70, respectively), compa

196 ized the Neisseria species and compared mean MIC levels between different antibiotic user groups.

197 ion of cephalosporins and the geometric mean MICs of ceftriaxone and cefixime (P < .05 for both compa

198 Meropenem MICs were determined in triplicate for each lot of conve

199 Up to 8-fold differences in meropenem MICs were observed between the commercial lots, resultin

200 recently described Drosophila tau(KO) and Mi{MIC} mutants and focused on molecular and behavioral ana

201 M23 tier 2 study design, broth microdilution MIC and disk diffusion quality control (QC) ranges were

202 00 mg*hour/L (assuming a broth microdilution MIC of 1 mg/L) to achieve clinical efficacy and ensure s

203 Broth microdilution MIC QC ranges spanned 3 to 4 doubling dilutions and cont

204 ved by the CLSI in 2017 (broth microdilution MIC) and 2019 (disk diffusion).

205 ment (CA) with reference broth microdilution MICs.

206 acronucleus (MAC) and germline micronucleus (MIC) of Tetrahymena thermophila differ in chromosome num

207 aluation of MICs in the context of the modal MIC for Enterobacterales and Pseudomonas aeruginosa, the

208 ovel parallel match scoring algorithm, named MIC-SDP (spectrum dot product), and its two-level parall

209 ns and contained 99.6% to 100.0% of obtained MIC values for the five reference strains.

210 Two hours of MIC exposure led to pathogen death due to cell lysis and

211 Interpretations of MIC or disk diffusion test results, such as "susceptible

212 The use of MIC made it possible to digest 700 mg of samples, and ag

213 non-extruded samples showing high values of MIC and MBC as the microorganisms tested were multi-resi

214 d Pseudomonas aeruginosa, the variability of MIC tests, and, possibly, resistance mechanisms is impor

215 monstrated to demosntrate the versatility of MIC in the DODA.

216 The association of MICs and treatment outcome in multidrug-resistant (MDR)-

217 Evaluation of MICs in the context of the modal MIC for Enterobacterale

218 ain Candida rugosa for further evaluation of MICs on the isolates.

219 BL-harboring isolates, the impact of EDTA on MICs was dependent on the lot, correlating with initial

220 y was not associated with gentamicin Cmax or MIC.

221 MICs inhibiting 50 and 90% of organisms (MIC(50) and MIC(90), respectively), essential agreement

222 This study led CLSI to adjust the oxacillin MIC breakpoints for SOSA.

223 , Fgd1 (DLM), and Rv0678 (BDQ) and performed MIC assays on a subset of MTBc strains carrying mutation

224 hesis- did not affect resistance phenotypes (MIC and growth rate with OTC), while blocking of protein

225 ies that showed near total resistant to PmB (MICs 384-1024 ug ml(-1) ) and colistin (MIC 256 ug ml(-1

226 esistant to the model AMP, polymyxin B (PmB, MICs 64-256 ug ml(-1) ).

227 ]pyrimidin-4(3H)-one) with improved potency (MIC = 19/38 muM), selectivity over normal gut microflora

228 nazolin-4(3H)-one (2) with moderate potency (MIC = 312/156 muM).

229 nt for future studies in associating precise MICs with specific resistance alleles.

230 The model predicted MICs with no a priori information about the underlying g

231 e also show that our approach for predicting MICs is stable over time, despite annual fluctuations in

232 ions identified by the models for predicting MICs.

233 ed as pellets and inserted into the proposed MIC system.

234 By using the proposed MIC-DV system, low volumes of diluted absorbing solution

235 displacement reaction is designed to protect MIC from decoding and falsification.

236 h (CAMHB) requires iron depletion to provide MICs predictive of in vivo activity.

237 A two-fold decrease in dilutions of PZA MIC for PZA susceptible strains showed no association wi

238 Susceptibility rates, MIC(50) values, and MIC(90) values were as follows: ceft

239 provides a platform for developing reference MIC assays that are robust against inoculum-density vari

240 compatibility complex class I chain-related (MIC) A and B (MICA and MICB) are polymorphic stress mole

241 rget attainment (PTA) at clinically relevant MICs.

242 Reporting MICs within the SDD category suggests that treatment suc

243 00%, 81% and 18% of patients at respectively MIC of 0.063, 0.125 and 0.25 mg/L achieved AUC24/MIC >=1

244 , 81%, and 18% of patients at, respectively, MIC of 0.063, 0.125, and 0.25 mg/L achieved AUC24/MIC >=

245 2-IPMA and 3-IPMA showed MICs values of 4096 mg/L and MBCs values of 8192 mg/L or

246 st A. fumigatus and B. dendrobatidis showing MIC values of 62.50 ug/mL and 31.25 ug/mL, respectively.

247 uated for colistin resistance using standard MIC testing by both agar dilution and broth microdilutio

248 0039 mug/mL) and drug-resistant Mtb strains (MIC = 0.0078 mug/mL).

249 activity against both the drug-susceptible (MIC = 0.0039 mug/mL) and drug-resistant Mtb strains (MIC

250 tested strains were penicillin-susceptible (MIC <0.06 mug/mL).

251 four-fold increase in P. aeruginosa TOL-TAZ MICs after exposure to TOL-TAZ.

252 cluding strains with piperacillin/tazobactam MIC values > 16 mg/L.

253 ptible, the value of piperacillin-tazobactam MICs is controversial.

254 ciated with elevated piperacillin/tazobactam MICs and the highest risk increase in 30-mortality of 14

255 The SDC (0.384) was slightly larger than MIC.

256 The MIC chromosomes have TAD-like structures but not A/B com

257 The MIC prediction models had an overall average accuracy of

258 The MIC values of gamma-lactam YU253434, 1, are reported alo

259 and 98% of Salmonella enteritidis at 2x the MIC.

260 and amoxicillin were 8-fold higher, and the MIC for cefotaxime was 3-fold higher than for near-isoge

261 and amoxicillin were 8-fold higher, and the MIC for cefotaxime was 3-fold higher than for near-isoge

262 oderate doses of antibiotics, well below the MIC of resistant strains, may effectively restrict de no

263 , respectively) were tested to determine the MIC of the strains as well as the heterogeneity in growt

264 entify three critical proteins governing the MIC proliferation and death, including FAK, mTORC1 and N

265 boundaries of the TAD-like structures in the MIC are highly consistent with the chromatin breakage se

266 of the mild detergent polysorbate 80 in the MIC assay.

267 A reduction in the MIC of ethidium bromide (a substrate for several efflux

268 oeugenol caused significant reduction in the MIC of the antibiotic, demonstrating synergistic effects

269 identify the midpoints of centromeres in the MIC.

270 We measured the MIC, MBC and MBIC of DMADDM and DMAHDM respectively.

271 ggesting that each TAD-like structure of the MIC chromosomes develops into one MAC chromosome during

272 omycin-susceptible) and 91.0%-97.9% when the MIC was 1 mg/L.

273 (every 24 hours) dose was 1.5%-5.5% when the MIC was 4 mg/L (ie, daptomycin-susceptible) and 91.0%-97

274 The MICs of CFDC were determined for 610 Gram-negative bacil

275 y to describe the dynamic regulations of the MICs, but also clearly identify three critical proteins

276 y were present at concentrations below their MIC and thus could act in synergy.

277 These MIC QC ranges were also approved by CLSI for use in futu

278 These MICs are susceptible by the 2018 breakpoints and not sus

279 rains from MIC = 2 mug/mL (acetazolamide) to MIC = 0.007 mug/mL (22) and 1 mug/mL (26).

280 ur susceptibility threshold in comparison to MIC across 64 more isolates confirmed the reliability of

281 g area under the concentration-time curve to MIC ratio (fAUC/MIC) threshold predictive of survival at

282 ere unlikely to be related or not related to MIC infusion.

283 s active against Mycobacterium tuberculosis (MIC = 4 ug/mL) and even against a multidrug-resistant (M

284 1.3 in MICs, and 3.0 in LICs, and four upper-MICs (Argentina, Chile, Turkey, and Poland) showed ratio

285 However, in HICs and some upper-MICs, deaths from cancer are now more common than those

286 Using MIC criteria for antimicrobial susceptibility in NG, we

287 A caveat of using MIC data for this purpose is heteroresistance, the prese

288 ve-induced combustion in disposable vessels (MIC-DV) for trace elements determination by inductively

289 or the approved dose are optimized only when MIC <=1 mg/L, these data continue to stress the importan

290 eumoniae (MSMp) were <=0.008 mug/ml, whereas MICs for MRMp were 16 to 32 mug/ml.

291 h higher initial zinc concentrations), while MICs for KPC-harboring isolates were unchanged.

292 , 12) showed marked antifungal activity with MIC < 2.0 uM.

293 hest (p < 0.05) antimicrobial activity, with MIC of 7.82 mM against S.

294 positive bacteria Staphylococcus aureus with MIC(50) values at 2-5 mug/mL.

295 iazid-resistant M. tuberculosis strains with MIC values of 9.46 and 9.90 muM, respectively.

296 resulted in a library of >50 compounds with MICs ranging from 3 to 800 muM against clinical isolates

297 the reference BMD method, and isolates with MICs of >=2 ug/ml should be evaluated for the presence o

298 lling is accomplished by all peptides at 5 x MIC.

299 nous acute dose toxicity studies up to 2-8 x MIC.

300 Some mcr-1-producing isolates yielded MICs of 2 ug/ml by CBDE and 4 ug/ml by BMD.